AGR2 Expression is Regulated by HIF-1 and Contributes to Growth and Angiogenesis of Glioblastoma

Cell Biochemistry and Biophysics

Volumn 67, Issue 3, 2013, Pages 1487-1495

  Hong, Xing Yu ^a   Wang, Jing ^b   Li, Zhe ^a  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^b JILIN AGRICULTURAL UNIVERSITY   (China)

Author keywords

Anterior gradient protein 2; Glioblastom Multiforme; Hypoxia; Hypoxia induced factor 1; Tumor angiogenesis

Indexed keywords

AGR2 PROTEIN, HUMAN; ARNT PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; MESSENGER RNA; NEUTRALIZING ANTIBODY; PROTEIN; RECOMBINANT PROTEIN; SMALL INTERFERING RNA; TUBULIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL HYPOXIA; CELL MOTION; CULTURE MEDIUM; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GLIOBLASTOMA; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; CULTURE MEDIA, CONDITIONED; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PROTEINS; RECOMBINANT PROTEINS; RNA, MESSENGER; RNA, SMALL INTERFERING; TUBULIN;

EID: 84888378291     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-013-9650-4     Document Type: Article

References (25)

1. Zhao, N., Sun, B. C., Sun, T., Ma, Y. M., Zhao, X. L., Liu, Z. Y., et al. (2012). Hypoxia-induced vasculogenic mimicry formation via VE-cadherin regulation by Bcl-2. Medical Oncology, 29(5), 3599-3607.
2. Facciabene, A., Peng, X., Hagemann, I. S., Balint, K., Barchetti, A., Wang, L. P., et al. (2011). Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. Nature, 475(7355), 226-230.
3. Oliver, L., Olivier, C., Marhuenda, F. B., Campone, M., & Vallette, F. M. (2009). Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy. Current Molecular Pharmacology, 2(3), 263-284.
4. Wang, G. L., & Semenza, G. L. (1995). Purification and characterization of hypoxia-inducible factor 1. Journal of Biological Chemistry, 270(3), 1230-1237.
5. Tanimoto, K., Makino, Y., Pereira, T., & Poellinger, L. (2000). Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO Journal, 19(16), 4298-4309.
6. Vajkoczy, P., Farhadi, M., Gaumann, A., Heidenreich, R., Erber, R., Wunder, A., et al. (2002). Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. Journal of Clinical Investigation, 109(6), 777-785.
7. Fiorenzo, P., Mongiardi, M. P., Dimitri, D., Cozzolino, M., Ferri, A., Montano, N., et al. (2010). HIF1-positive and HIF1-negative glioblastoma cells compete in vitro but cooperate in tumor growth in vivo. International Journal of Oncology, 36(4), 785-791.
8. Miletic, H., Niclou, S. P., Johansson, M., & Bjerkvig, R. (2009). Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms. Expert Opinion on Therapeutic Targets, 13(4), 455-468.
9. Thompson, D. A., & Weigel, R. J. (1998). hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines. Biochemical and Biophysical Research Communications, 251(1), 111-116.
10. Komiya, T., Tanigawa, Y., & Hirohashi, S. (1999). Cloning of the gene gob-4, which is expressed in intestinal goblet cells in mice. Biochimica et Biophysica Acta, 1444(3), 434-438.
11. Aberger, F., Weidinger, G., & Grunz, H. (1998). Anterior specification of embryonic ectoderm: The role of the Xenopus cement gland-specific gene XAG-2. Mechanisms of Development, 72(1-2), 115-130.
12. Liu, D., Rudland, P. S., Sibson, D. R., Platt-Higgins, A., & Barraclough, R. (2005). Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas. Cancer Research, 65(9), 3796-3805.
13. Fritzsche, F. R., Dahl, E., Pahl, S., Burkhardt, M., Luo, J., Mayordomo, E., et al. (2006). Prognostic relevance of AGR2 expression in breast cancer. Clinical Cancer Research, 12(6), 1728-1734.
14. Innes, H. E., Liu, D., Barraclough, R., Davies, M. P., O'Neill, P. A., Platt-Higgins, A., et al. (2006). Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients. British Journal of Cancer, 94(7), 1057-1065.
15. Groome, M., Lindsay, J., Ross, P. E., Cotton, J. P., Hupp, T. R., & Dillon, J. F. (2008). Use of oesophageal stress response proteins as potential biomarkers in the screening for Barrett's oesophagus. European Journal of Gastroenterology and Hepatology, 20(10), 961-965.
16. Wang, Z., Hao, Y., & Lowe, A. W. (2008). The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation. Cancer Research, 68(2), 492-497.
17. Ramachandran, V., Arumugam, T., Wang, H., & Logsdon, C. D. (2008). Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Research, 68(19), 7811-7818.
18. Zhu, H., Lam, D. C., Han, K. C., Tin, V. P., Suen, W. S., Wang, E., et al. (2007). High resolution analysis of genomic aberrations by metaphase and array comparative genomic hybridization identifies candidate tumour genes in lung cancer cell lines. Cancer Letters, 245(1-2), 303-314.
19. Zhang, Y., Ali, T. Z., Zhou, H., D'Souza, D. R., Lu, Y., Jaffe, J., et al. (2010). ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer. Cancer Research, 70(1), 240-248.
20. Pohler, E., Craig, A. L., Cotton, J., Lawrie, L., Dillon, J. F., Ross, P., et al. (2004). The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage. Molecular and Cellular Proteomics, 3(6), 534-547.
21. Kissler, S., Stern, P., Takahashi, K., Hunter, K., Peterson, L. B., & Wicker, L. S. (2006). In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes. Nature Genetics, 38(4), 479-483.
22. Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., et al. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Molecular and Cellular Biology, 16(9), 4604-4613.
23. Ke, Q., & Costa, M. (2006). Hypoxia-inducible factor-1 (HIF-1). Molecular Pharmacology, 70(5), 1469-1480.
24. Mercapide, J., Lopez De Cicco, R., Castresana, J. S., & Klein-Szanto, A. J. (2003). Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines. International Journal of Cancer, 106(5), 676-682.
25. Reardon, D. A., Turner, S., Peters, K. B., Desjardins, A., Gururangan, S., Sampson, J. H., et al. (2011). A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma. Journal of the National Comprehensive Cancer Network, 9(4), 414-427.